Unfortunately, a study (10) that described that a similar fraction of T cell clones derived from MS patients and healthy donors co-expressed IFN-γ and GM-CSF did not include FOXP3 as an additional marker, which would be an interesting subject of future investigation to identify the in vivo occurrence and potential relevance of such triple-positive cells. This evidence concerns the gene IFNG and myeloid sarcoma.